165 related articles for article (PubMed ID: 38474362)
21. MicroRNA-18a regulates the metastatic properties of oral squamous cell carcinoma cells via HIF-1α expression.
Kim S; Park S; Oh JH; Lee SS; Lee Y; Choi J
BMC Oral Health; 2022 Sep; 22(1):378. PubMed ID: 36064348
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia-induced ROS promotes mitochondrial fission and cisplatin chemosensitivity via HIF-1α/Mff regulation in head and neck squamous cell carcinoma.
Wu K; Mao YY; Chen Q; Zhang B; Zhang S; Wu HJ; Li Y
Cell Oncol (Dordr); 2021 Oct; 44(5):1167-1181. PubMed ID: 34460078
[TBL] [Abstract][Full Text] [Related]
23. Galectin 3 expression in primary oral squamous cell carcinomas.
Weber M; Büttner-Herold M; Distel L; Ries J; Moebius P; Preidl R; Geppert CI; Neukam FW; Wehrhan F
BMC Cancer; 2017 Dec; 17(1):906. PubMed ID: 29284429
[TBL] [Abstract][Full Text] [Related]
24. Increased malignancy of oral squamous cell carcinomas (oscc) is associated with macrophage polarization in regional lymph nodes - an immunohistochemical study.
Wehrhan F; Büttner-Herold M; Hyckel P; Moebius P; Preidl R; Distel L; Ries J; Amann K; Schmitt C; Neukam FW; Weber M
BMC Cancer; 2014 Jul; 14():522. PubMed ID: 25042135
[TBL] [Abstract][Full Text] [Related]
25. PX-12 synergistically enhances the therapeutic efficacy of vorinostat under hypoxic tumor microenvironment in oral squamous cell carcinoma in vitro.
Akhlaq R; Khan T; Ahmed T; Musharraf SG; Ali A
Drug Dev Res; 2023 May; 84(3):556-560. PubMed ID: 36808757
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant concurrent radiochemotherapy followed by surgery in advanced oral squamous cell carcinoma (OSCC): a retrospective analysis of 207 patients.
Freier K; Engel M; Lindel K; Flechtenmacher C; Mühling J; Hassfeld S; Hofele C
Oral Oncol; 2008 Feb; 44(2):116-23. PubMed ID: 17350327
[TBL] [Abstract][Full Text] [Related]
27. [18F]fluoro-2-deoxyglucose-positron emission tomography for the assessment of histopathological response after preoperative chemoradiotherapy in advanced oral squamous cell carcinoma.
Shimomura H; Sasahira T; Yamanaka Y; Kurihara M; Imai Y; Tamaki S; Yamakawa N; Shirone N; Hasegawa M; Kuniyasu H; Kirita T
Int J Clin Oncol; 2015 Apr; 20(2):308-16. PubMed ID: 24942501
[TBL] [Abstract][Full Text] [Related]
28. Poor prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinomas that overexpress hypoxia inducible factor-1α.
Swartz JE; Pothen AJ; van Kempen PM; Stegeman I; Formsma FK; Cann EM; Willems SM; Grolman W
Head Neck; 2016 Sep; 38(9):1338-46. PubMed ID: 27027530
[TBL] [Abstract][Full Text] [Related]
29. Siah-1 is associated with expression of hypoxia-inducible factor-1α in oral squamous cell carcinoma.
Aga M; Kondo S; Wakisaka N; Moriyama-Kita M; Endo K; Nakanishi Y; Murono S; Sugimoto H; Ueno T; Yoshizaki T
Auris Nasus Larynx; 2017 Apr; 44(2):213-219. PubMed ID: 27616748
[TBL] [Abstract][Full Text] [Related]
30. Survival Impact of Surgical Resection in Locally Advanced T4b Oral Squamous Cell Carcinoma.
Gangopadhyay A; Bhatt S; Nandy K; Rai S; Rathod P; Puj KS
Laryngoscope; 2021 Jul; 131(7):E2266-E2274. PubMed ID: 33459389
[TBL] [Abstract][Full Text] [Related]
31. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
Eckert AW; Lautner MH; Schütze A; Taubert H; Schubert J; Bilkenroth U
Histopathology; 2011 Jun; 58(7):1136-47. PubMed ID: 21438910
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
Finnegan V; Parsons JT; Greene BD; Sharma V
Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
[TBL] [Abstract][Full Text] [Related]
33. Significance of HIF-1α and CD105 in establishing oral squamous cell carcinoma associated with oral submucous fibrosis a distinct clinicopathological entity.
Hande AH; Chaudhary MS; Gadbail AR; Gawande MN; Patil SK; Zade PR; Sharma PN; Jaiswal SG; Sonone AM
J Cancer Res Ther; 2022; 18(1):33-41. PubMed ID: 35381759
[TBL] [Abstract][Full Text] [Related]
34. [CD103
Li BW; Ren SQ; Chen SL; Lan TJ; Wu F; Li JS
Zhonghua Kou Qiang Yi Xue Za Zhi; 2023 Dec; 58(12):1257-1264. PubMed ID: 38061868
[No Abstract] [Full Text] [Related]
35. Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma.
Wise-Draper TM; Gulati S; Palackdharry S; Hinrichs BH; Worden FP; Old MO; Dunlap NE; Kaczmar JM; Patil Y; Riaz MK; Tang A; Mark J; Zender C; Gillenwater AM; Bell D; Kurtzweil N; Mathews M; Allen CL; Mierzwa ML; Casper K; Jandarov R; Medvedovic M; Lee JJ; Harun N; Takiar V; Gillison M
Clin Cancer Res; 2022 Apr; 28(7):1345-1352. PubMed ID: 35338369
[TBL] [Abstract][Full Text] [Related]
36. Tumor Microenvironment Status Predicts the Efficacy of Postoperative Chemotherapy or Radiochemotherapy in Resected Gastric Cancer.
Duan R; Li X; Zeng D; Chen X; Shen B; Zhu D; Zhu L; Yu Y; Wang D
Front Immunol; 2020; 11():609337. PubMed ID: 33569057
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of patients with squamous cell carcinoma of esophagus who did not receive surgical resection after neoadjuvant radiochemotherapy.
Fakhrian K; Ordu AD; Nieder C; Lordick F; Kup PG; Theisen J; Combs SE; Geinitz H
Tumori; 2015; 101(3):263-7. PubMed ID: 25908044
[TBL] [Abstract][Full Text] [Related]
38. Prognostic implications of preoperative systemic inflammatory markers in oral squamous cell carcinoma, and correlations with the local immune tumor microenvironment.
Ruiz-Ranz M; Lequerica-Fernández P; Rodríguez-Santamarta T; Suárez-Sánchez FJ; López-Pintor RM; García-Pedrero JM; de Vicente JC
Front Immunol; 2022; 13():941351. PubMed ID: 35958590
[TBL] [Abstract][Full Text] [Related]
39. Differentiated embryo chondrocyte 1, induced by hypoxia-inducible factor 1α, promotes cell migration in oral squamous cell carcinoma cell lines.
Yang L; Zeng L; Wang Z; Hu X; Xiong H; Zhang T; Chen W; Xia K; Su T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Feb; 133(2):199-206. PubMed ID: 34758939
[TBL] [Abstract][Full Text] [Related]
40. Association between radiation dose and pathological complete response after preoperative radiochemotherapy in esophageal squamous cell cancer.
Ordu AD; Nieder C; Geinitz H; Scherer V; Kup PG; Schuster T; Combs SE; Fakhrian K
Anticancer Res; 2014 Dec; 34(12):7255-61. PubMed ID: 25503157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
